Data as of Sep 29, 2026 · Based on 79 AI responses · See how Parse measures this
ScreenPoint Medical's Transpara Detection is an AI system for breast cancer screening that categorizes mammogram exams into risk levels and highlights suspicious regions. It has been validated in over 10 million mammograms across 30+ countries, including a randomized controlled trial showing a 29% increase in cancer detection and 44% reduction in radiologist workload.
4%1% before. Up 3 points.
of AI answers about Transpara and its rivals. Week of Sep 21
“Transpara by ScreenPoint Medical (Breast Cancer): A widely deployed CE-marked and FDA-cleared support tool that acts as a "second pair of eyes" on mammograms”
“Transpara from ScreenPoint Medical received FDA clearance in August 2026.”
AI mentioned Transpara in 4% of answers about Transpara and its rivals in the week of Sep 21.
Transpara is a product of ScreenPoint Medical.
Excerpts where Transpara appeared in the AI's answer
Transpara by ScreenPoint Medical (Breast Cancer): A widely deployed CE-marked and FDA-cleared support tool that acts as a "second pair of eyes" on mammograms
Transpara from ScreenPoint Medical received FDA clearance in August 2026.
